Monogram Orthopaedics price target raised to $5.40 from $4 at Roth MKM
Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares. The company’s ...
Sacramento Bee9d
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
I'm incredibly impressed and confident that surgeons will recognize the impact of this system," said Dr. Douglas Unis, Founder and Chief Medical Officer of Monogram. "Navigating a regulatory ...